Open AccessRheumatic Valve Disease Surgery: Major Challenge in BURUNDI
Author(s) -
Macédoine Nijimbere,
Issaka Zallé,
Abdoulaziz Thiombiano,
Son Moussa,
Yves Marien Mpira,
Eugène Ndirahisha,
Pierre Claver Niyonzima,
Elysée Baransaka,
Drissi Boumzebra
Publication year - 2022
Publication title -
sas journal of surgery
Language(s) - English
Resource type - Journals
ISSN - 2454-5104
DOI - 10.36347/sasjs.2022.v08i04.009
Subject(s) - medicine , rheumatic disease , heart disease , surgery , mitral valve , rheumatic fever , mitral valve replacement , disease , cardiology
Objective: to show major challenge, concerns about rheumatic valve disease surgery in Burundi and medium term results. Methods: Included in our study, all patients whom the diagnosis of rheumatic heart disease had been made and underwent open heart surgery abroad. Results: Middle age= 24, 72 ±11.8 years, 33 (61.1%) patients were female. The average duration of the follow up=3.46±1.61years. Mitral valve was the most affected (92.59%). The main surgical procedure was mitral valve replacement performed to 47 (94%) patients. During the follow up, 3(5.5%) patients died. Conclusion: Surgical management of rheumatic heart disease remains a major challenge in Burundi. Six areas of concerns must be considered to developp a local technique plateau.